As of February 10, 2023, the average one-year price target for Cyclo Therapeutics is $5.10. The forecasts range from a low of $5.05 to a high of $5.25. The average price target represents an increase ...
We recently compiled a list of the 10 Best Micro Cap Stocks to Buy Now. In this article, we are going to take a look at where Cyclo Therapeutics, Inc. (NASDAQ:CYTH) stands against the other micro cap ...
Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Cyclo Therapeutics, Inc. (NASDAQ: CYTH) and Applied Molecular Transport Inc. is fair to ...
Cyclo Therapeutics, Inc. (CYTH) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to loss of $0.29 per share a year ago. These ...
Ctd Holdings Inc (CYTH) stock has faced a significant downturn, touching a 52-week low of $0.59, marking a stark contrast to its performance over the past year. According to InvestingPro data, the ...
NEW YORK, Aug. 26, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches ...
GAINESVILLE, Fla., February 07, 2025--Cyclo Therapeutics, Inc. (Nasdaq: CYTH) ("Cyclo Therapeutics" or the "Company"), a clinical stage biotechnology company dedicated to developing life-changing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results